In fact, increased Wnt signalling has been reported to induce therapeutic resistance in glioblastoma, ovarian cancer or non-small cell lung carcinoma [144], most likely by increasing the expression of ABC transporters, such as Pgp [145] or BCRP [146]. The gene discussed is ABCG2; the disease is ovarian carcinoma.